Home > Protocol Summaries: Compounds > GSK1014802

Protocol Summaries: GSK1014802

Protocol Summaries for GSK1014802
GSK
Study ID		 Phase Title Status
107727 Phase 1 Single-blind, randomised, placebo-controlled study to assess the safety, tolerability and pharmacokinetics of repeat doses of GSK1014802 and its interaction with food in healthy volunteers Completed
111676 Phase 1 A double blind, double dummy, placebo controlled cross over study with a positive control to investigate the effect of a GSK drug on electrical hyperalgesia and threshold tracking in healthy subjects Terminated
113210 Phase 1 A Randomized, double-blind, placebo-controlled cross-over study to investigate the effect of GSK1014802 on Ambulatory Blood Pressure Completed

Filter list by: